| First Author | Mishra A | Year | 2016 |
| Journal | Exp Cell Res | Volume | 346 |
| Issue | 2 | Pages | 188-97 |
| PubMed ID | 27371158 | Mgi Jnum | J:315428 |
| Mgi Id | MGI:6830403 | Doi | 10.1016/j.yexcr.2016.06.019 |
| Citation | Mishra A, et al. (2016) Role of antigen presenting cell invariant chain in the development of hepatic steatosis in mouse model. Exp Cell Res 346(2):188-97 |
| abstractText | The role of Invariant chain (CD74 or Ii) in antigen presentation via Antigen Presenting Cells (APC), macrophage recruitment as well as survival, T cell activation and B cell differentiation has been well recognized. However, the aspect of CD74 which is involved in the development of hepatic steatosis and the pathways through which it acts remain to be studied. In this study, we investigated the role of CD74 in the inflammatory pathway and its contribution to development of hepatic steatosis. For this, wild type C57BL/6J and CD74 deficient mice (Ii(-/-) mice) were fed with high fat high fructose (HFHF) diet for 12 weeks. Chronic consumption of this feed did not develop hepatic steatosis, glucose intolerance or change in the level of immune cells in Ii(-/-) mice. Moreover, there was relatively delayed expression of genes involved in development of non alcoholic fatty liver disease (NAFLD) in HFHF fed Ii(-/-) mice as compared to that of C57BL/6J phenotype. Taken together, the data suggest that HFHF diet fed Ii(-/-) mice fail to develop hepatic steatosis, suggesting that Ii mediated pathways play a vital role in the initiation and propagation of liver inflammation. |
